Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 1997

View Archived Issues

Andrx seeks patent coverage for new drug delivery system

Patent coverage obtained for SomatoKine in osteoporosis, tissue repair

Positive preclinical results obtained with Avigen's antiparkinsonian gene therapy

Pseudopeptide derivatives of OGP and OGP(10-14) disclosed by Yissum

Pharmacological characterization of CCD-3693, an orally available neuroactive steroid

Thalidomide proves effective in HIV-associated proctitis

Effects of rPAF-AH in opossums with severe pancreatitis

Safety and biochemical effects of DFMO support phase III trials for colon cancer prevention

Insulin therapy found useful in patients with type II diabetes

United Biomedical and California lab to collaborate on novel HIV therapeutic

Preliminary phase III data presented on celecoxib at arthritis symposium

Enbrel phase III and long-term safety data presented at rheumatology meeting

Update on Prizm's novel Directin-based product pipeline

Alza: Q3 1997 highlights

New ACAT inhibitor from Pierre Fabre

GL-701 shows significant steroid-sparing effects in women with active SLE

Synvisc introduced in U.S.

Novartis' NK1 antagonist in clinical studies for pain

Matritech: Q3 1997 highlights

Beclometasone CFC-free MDI for chronic bronchial asthma approved

FDA advisory committee recommends approval of Prandin

Life Medical Sciences: Q2 and nine-month 1997 highlights

Nortran and Bridge Pharma to develop dermal anesthetics

FDA advisory committee to review rotavirus vaccine

Extensive preclinical results described for new NK2 antagonist

HMR and MediGene collaborate on cancer gene therapies

Phase II results with T-cell receptor peptides in RA promising

Phase II begins for psoriasis vaccine

New NK3/NK4 antagonist in the pipeline at SKB

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...